Oedema risk with insulin pumps

Diabetes patients may be at risk of oedema and neuropathy if they have rapid improvements in glycaemic control, endocrinologists warn.

Sudden intensification of insulin therapy and glycaemic control as seen with commencement of insulin pump therapy may result in oedema and neuropathic pain, according to specialists from Sir Charles Gairdner Hospital in Perth.

In a report published in Diabetes